Sonova (OTCMKTS:SONVY) Share Price Passes Above Fifty Day Moving Average – Here’s Why
by Renee Jackson · The Cerbat GemSonova Holding (OTCMKTS:SONVY – Get Free Report)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $48.45 and traded as high as $49.36. Sonova shares last traded at $48.32, with a volume of 14,051 shares changing hands.
Analysts Set New Price Targets
A number of equities research analysts recently commented on SONVY shares. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th. BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Finally, Citigroup reiterated a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Two research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy”.
Check Out Our Latest Analysis on Sonova
Sonova Price Performance
The business has a 50-day simple moving average of $48.50 and a two-hundred day simple moving average of $49.96. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.43 and a current ratio of 1.75.
About Sonova
Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.
Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.